Clinical Trials

Neoplasms, Unknown Primary

NCT03752333 2026-01-22

CUPem

35 enrolled

Phase 2 Active not recruiting

Neoplasms, Unknown Primary

NCT03391973 2025-04-25

CUP

26 enrolled

Neoplasms, Unknown Primary

NCT06695494 2025-01-09

EGGCUP

Recruiting

100 enrolled

Neoplasms, Neoplasms, Unknown Primary

NCT04750109 2024-10-10

CUP-COMP

117 enrolled

Neoplasms, Unknown Primary

NCT05841966 2024-05-07

OP-CUP

Phase NA Completed

30 enrolled

Carcinoma, Squamous Cell, Neoplasms, Unknown Primary

NCT05263700 2023-03-31

FAPI-CUP

Phase NA Unknown

150 enrolled

Neoplasms, Unknown Primary

NCT03278600 2022-01-24

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

182 enrolled

Neoplasms, Unknown Primary

NCT04952103 2021-07-07

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

Unknown

200 enrolled

Neoplasms, Unknown Primary

NCT00003526 2020-12-17

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Phase 2 Terminated

8 enrolled 5 charts

Neoplasms, Unknown Primary

NCT04131621 2020-04-15

CheCUP

Phase 2 Unknown

194 enrolled

Neoplasms, Unknown Primary

NCT01540058 2020-02-17

GEFCAPI04

243 enrolled

Neoplasms, Unknown Primary

NCT02628379 2018-07-10

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

125 enrolled

Neoplasm Metastasis, Neoplasms, Unknown Primary

NCT00047125 2018-07-09

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

600 enrolled

Neoplasms, Unknown Primary

NCT00066781 2017-04-04

Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

31 enrolled 8 charts

Neoplasms, Unknown Primary

NCT00936702 2017-03-21

Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

46 enrolled 13 charts

Neoplasms, Unknown Primary

NCT00201734 2016-09-23

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Phase 1/2 Terminated

57 enrolled 11 charts

Adenocarcinoma, Neoplasms, Neoplasms, Unknown Primary

NCT00873119 2015-07-28

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

89 enrolled 12 charts

Neoplasms, Unknown Primary

NCT00458315 2015-05-08

Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Phase 2 Withdrawn

Neoplasms, Unknown Primary

NCT00360360 2013-12-04

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

60 enrolled 6 charts

Neoplasms, Unknown Primary

NCT00876408 2013-12-04

Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer

30 enrolled

Neoplasms, Unknown Primary

NCT00193609 2013-11-11

Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

48 enrolled 6 charts

Neoplasms, Unknown Primary

NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Phase 3 Unknown

Neoplasms, Unknown Primary

NCT00003558 2013-08-07

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

Phase 3 Unknown

140 enrolled

Neoplasms, Unknown Primary

NCT00193596 2013-05-03

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site

198 enrolled 7 charts

Neoplasms, Unknown Primary

NCT01202786 2012-08-15

Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

60 enrolled

Neoplasms, Unknown Primary

NCT00353145 2012-08-02

Gemox as First and Second Line Therapy in Unknown Primary Cancer

29 enrolled

Neoplasms, Unknown Primary

NCT00269373 2012-02-22

Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

136 enrolled

Neoplasms, Unknown Primary

NCT00894569 2009-05-14

PACET-CUP

Phase 2 Unknown

150 enrolled

Carcinoma, Neoplasms, Unknown Primary

NCT00148135 2008-01-10

Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

Phase 2 Terminated